Spectrum of activity of lamotrigine in treatment-refractory bipolar disorder

American Journal of Psychiatry

Volumn 156, Issue 7, 1999, Pages 1019-1023

  Calabrese, Joseph R ^a,b,c,d   Bowden, Charles L ^a,b,c   McElroy, Susan L ^a,b,c   Cookson, John ^a,b,c   Andersen, John ^a,b,c   Keck Jr , Paul E ^a,b,c   Rhodes, Linda ^a,b,c   Bolden Watson, Carolyn ^a,b,c   Zhou, Jing ^a,b,c   Ascher, John A ^a,b,c  

^a Amer Coll Neuropsychopharmacology   (Puerto Rico)

^b Vordingborg Hospital   (Denmark)

^c GLAXOSMITHKLINE   (United States)

^d CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; CARBAMAZEPINE; LAMOTRIGINE; LITHIUM; NEUROLEPTIC AGENT; VALPROIC ACID;

ADULT; AGED; ARTICLE; DEPRESSION; DRUG EFFICACY; DRUG SAFETY; FEMALE; HEADACHE; HUMAN; HYPOMANIA; MAJOR CLINICAL STUDY; MALE; MANIA; MANIC DEPRESSIVE PSYCHOSIS; NAUSEA; PRIORITY JOURNAL; RASH; SOMNOLENCE; TREMOR; VERTIGO;

ADULT; AGED; ANTICONVULSANTS; ANTIMANIC AGENTS; BIPOLAR DISORDER; DRUG ERUPTIONS; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PSYCHIATRIC STATUS RATING SCALES; TREATMENT OUTCOME; TRIAZINES;

EID: 0032969706     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Calabrese JR, Bowden CL, Woyshville MJ: Lithium and anticonvulsants in bipolar disorder, in Psychopharmacology: The Fourth Generation of Progress. Edited by Bloom FE, Kupfer DJ. New York, Raven Press, pp 1099-1111
2. Calabrese JR, Woyshville MJ, Kimmel SE, Rapport DJ: Mixed states and bipolar rapid cycling and their treatment with valproate. Psychiatr Annals 1993; 23:70-78
3. McElroy SL, Keck PE Jr, Pope HG Jr, Hudson JI, Faedda GL, Swann AC: Clinical and research implications of the diagnosis of mixed mania or hypomania. Am J Psychiatry 1992; 149: 1633-1644
4. Strakowski SM, McElroy SL, Keck PE Jr, West SA: Suicidality among patients with mixed and manic bipolar disorder. Am J Psychiatry 1996; 153:674-676
5. Bauer MS, Calabrese J, Dunner DL, Post R, Whybrow PC, Gyulai L, Tay LK, Younkin SR, Bynum D, Lavori P, Price RA: Multisite data reanalysis of the validity of rapid cycling as a course modifier for bipolar disorder in DSM-IV. Am J Psychiatry 1994; 151:506-515
6. Schachter SC, Leppik E, Matsuo F, Messenheimer JA, Faught E, Moore EL, Risner ME: Lamotrigine: a six month, placebo-controlled, safety and tolerance study. J Epilepsy 1995; 8: 201-209
7. Messenheimer J, Ramsay R, Willmore L, Leroy R, Zielinski J, Mattson R, Pellock J, Valakas A, Woulbe G, Risner M: Lamotrigine therapy for partial seizures: a multicenter placebo-controlled, double-blind cross-over trial. Epilepsia 1994; 35:113-121
8. Chang G, Vasquez B, Gilliam F, Sackellares JC, Burns P, Risner M, Rudd GD: Lamictal (lamotrigine) monotherapy is an effective treatment for partial seizures (abstract). Neurology 1997; 48:A335
9. Brodie M, Richens A, Yuen A, UK Lamotrigine/Carbamazepine Monotherapy Trial Group: Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy. Lancet 1995; 345:476-479
10. Matsuo F, Bergen D, Faught E, Messenheimer JA, Dren AT, Rudd GD, Lineberry CG, US Lamotrigine Protocol 05 Clinical Trial Group: Placebo-controlled study of the efficacy and safety of lamotrigine in patients with partial seizures. Neurology 1993; 43:2284-2291
11. Smith D, Chadwick D, Baker G, Davis G, Dewey M: Seizure severity and the quality of life. Epilepsia 1993; 34(suppl 5): S31-S35
12. Weisler R, Risner ME, Ascher J, Houser T: Use of lamotrigine in the treatment of bipolar disorder, in 1994 Annual Meeting New Research Program and Abstracts. Washington, DC, American Psychiatric Association, 1994, p 216
13. Calabrese JR, Fatemi SH, Woyshville MJ: Antidepressant effects of lamotrigine in rapid cycling bipolar disorder (letter). Am J Psychiatry 1996; 153:1236
14. Walden J, Hesslinger B, van Calker D, Berger M: Addition of lamotrigine to valproate may enhance efficacy in the treatment of bipolar affective disorder. Pharmacopsychiatry 1996; 29:193-195
15. Sporn J, Sachs G: The anticonvulsant lamotrigine in treatment-resistant manic-depressive illness. J Clin Psychopharmacol 1997; 17:185-189
16. Kusumakar V, Yatham LN: Lamotrigine in treatment refractory bipolar depression. Psychiatry Res 1997; 72:145-148
17. Mandoki M: Lamotrigine/valproate in treatment resistant bipolar disorder in children and adolescents (abstract). Biol Psychiatry 1997; 41 (suppl):93S
18. Spitzer RL, Endicott J: Schedule for Affective Disorders and Schizophrenia - Change Version, 3rd ed. New York, New York State Psychiatric Institute, Biometrics Research, 1978
19. Endicott J, Spitzer RL, Fleiss JL, Cohen J: The Global Assessment Scale: a procedure for measuring overall severity of psychiatric disturbance. Arch Gen Psychiatry 1976; 33:766-771
20. Physicians' Desk Reference, 51st ed. Montvale, NJ, Medical Economics Co, 1997, pp 1105-1110